Capturing glucose variability in patients with diabetes

Abstract

Measurement of glycated haemoglobin (HbA1c) as a marker of glycaemic control has become a cornerstone in the management of diabetes, while also predicting cardiovascular risk. However, this does not fully capture fluctuations in glucose levels – glucose variability – which has recently emerged as a significant independent risk factor. This article considers clinical approaches to capturing glucose variability that may help improve glycaemic control in diabetes in the future.